The Justice Department announced that a federal grand jury in Kansas City, Kansas, returned an indictment charging Colton Donner, 25, with threatening an African-American male juvenile, because of the victim’s race and because the victim was living in a home in Paola, Kansas, in violation of Title 42, U.S. Code, Section 3631.
For a separate incident, Donner was charged with unlawfully possessing a firearm while being a convicted felon, in violation of Title 18, U.S. Code, Section 922(g)(1) and 924(a)(2).
The indictment alleges that Donner shouted racial slurs and brandished a knife, a dangerous weapon, at the victim in Paola, Kansas. The indictment further alleges that Donner, knowing he was a convicted felon, possessed .44 caliber revolver.
An indictment is merely an allegation, and the defendant is presumed innocent unless and until proven guilty. Donner faces a maximum sentence of 10 years in prison and a $250,000 fine for both the civil rights and firearm charges.
The case is being investigated by the Kansas City Field Office of the FBI. The case is being prosecuted by Assistant U.S. Attorney Tristan Hunt of the United States Attorney’s Office and Trial Attorney Anita Channapati of the Civil Rights Division’s Criminal Section.
- Mary Ida Townson Appointed U.S. Trustee for Florida, Georgia, Puerto Rico and the U.S. Virgin IslandsBy Sam NewsMay 5, 2021Attorney General Merrick B. Garland has appointed Mary Ida Townson as the U.S. Trustee for Florida, Georgia, the Commonwealth of Puerto Rico and the U.S. Virgin Islands (Region 21). Ms. Townson will assume her duties in June and will replace Nancy Gargula, who is the U.S. Trustee in Region 10 and who has served as the interim U.S. Trustee in Region 21 since April 2019.[Read More…]
- Justice Department Settles Sex Discrimination Lawsuit Alleging Disparate Treatment Against Female Correctional Officers by the Michigan Department of CorrectionsBy Sam NewsFebruary 18, 2021The Justice Department today announced that it has reached a settlement, through a court-supervised settlement agreement, with the State of Michigan and the Michigan Department of Corrections (MDOC) to resolve a sex discrimination lawsuit brought by the United States of America.[Read More…]
- Man Pleads Guilty to Stealing Nude Photos of Dozens of VictimsBy Sam NewsFebruary 9, 2021A New York man pleaded guilty Monday to computer fraud and aggravated identity theft related to his hacking of online social media accounts and theft of nude images of dozens of female victims.[Read More…]
- Secretary Antony J. Blinken with Birta Bjornsdottir of RikisutvarpioBy Sam NewsMay 21, 2021Antony J. Blinken, [Read More…]
- Iraq Travel AdvisoryBy Sam NewsIn TravelSeptember 26, 2020Do not travel to Iraq [Read More…]
- Extradición histórica lleva a miembros del ELN a Texas por narcoterrorismo y distribución internacional de cocaínaBy Sam NewsIn Justice NewsAugust 21, 2021Dos presuntos miembros [Read More…]
- Secretary Blinken’s Call with Czech Prime Minister BabišBy Sam NewsMay 2, 2021
- On the Death of ISIS-GS leader Adnan Abu Walid Al-SahrawiBy Sam NewsSeptember 17, 2021Ned Price, Department [Read More…]
- Federal Reserve Lending Programs: Credit Markets Served by the Programs Have Stabilized, but Vulnerabilities RemainBy Sam NewsOctober 19, 2021What GAO Found The Board of Governors of the Federal Reserve System (Federal Reserve) authorized 13 lending programs—known as facilities—to ensure the flow of credit to various parts of the economy affected by the COVID-19 pandemic. The last of the nine facilities supported through CARES Act funding ceased purchasing assets, such as corporate bonds, or extending credit by January 8, 2021. As of September 1, 2021, the CARES Act facilities held about $19 billion in assets. The Federal Reserve oversight reviews completed in December 2020 identified opportunities to enhance certain areas, including internal process and controls. These reviews also identified areas for continued monitoring, such as cybersecurity and conflicts of interest. GAO found that Federal Reserve's plans for ongoing monitoring of the facilities align with federal internal control standards for ongoing monitoring of an entity's internal control system. Available indicators suggest the facilities helped improve access to credit and liquidity in the corporate and municipal credit markets. For example, corporate bond spreads (which reflect borrowing costs) have remained low, and municipal spreads have decreased to prepandemic levels. Also, officials from state and local entities that participated in the Municipal Liquidity Facility (which targeted the municipal bond market) generally said the facility was beneficial and helped restore investor confidence in the municipal bond market. However, corporate and municipal credit markets remain vulnerable. For corporate credit markets, corporate bonds outstanding remain elevated and the high level of debt leaves businesses vulnerable to distress. Municipal credit markets also remain vulnerable because of the pandemic's extended duration, which may adversely affect local economies. According to surveys of small and independent businesses and lenders, access to credit has improved, but recovery remains slow, including for businesses in the services sector. Loans made under the Main Street facilities (which targeted small and mid-sized businesses and nonprofits) were concentrated among small for-profit businesses in certain economic sectors, such as restaurants. According to GAO's generalizable survey of Main Street borrowers, an estimated 88 percent said that the program was “very important” in helping them maintain operations. Women-owned businesses participated at lower rates compared to their representation among U.S. businesses. Although estimates of veteran- and minority-owned business participation were somewhat lower compared to their representation among U.S. businesses, the differences were not statistically significant (see figure). Estimated Participation of Business Types in the Main Street Lending Program Why GAO Did This Study On July 30, 2021, the last of the 13 Federal Reserve lending facilities stopped purchasing assets or extending credit. However, some of these facilities, including facilities that were supported through Department of the Treasury funding appropriated under section 4003(b)(4) of the CARES Act, continue to hold outstanding assets and loans. The Federal Reserve will continue to monitor and manage the facilities until these assets and loans are no longer outstanding. The CARES Act included a provision for GAO to periodically report on section 4003 loans, loan guarantees, and investments. This report examines the Federal Reserve's continued oversight and monitoring of the CARES Act facilities; what available evidence suggests about the facilities' effects on corporate credit markets, states and municipalities, and small businesses; and the characteristics of Main Street Lending Program participants, among other things. GAO reviewed applicable laws and agency and Federal Reserve Bank documentation; analyzed agency and other data on the facilities and credit markets; interviewed Federal Reserve and Treasury officials and representatives of state and local governments; and conducted a generalizable survey of for-profit Main Street borrowers. For more information, contact Michael E. Clements at (202) 512-8678 or firstname.lastname@example.org.[Read More…]
- Secretary Blinken’s Participation in the Mekong-U.S. Partnership Ministers’ MeetingBy Sam NewsAugust 3, 2021
- Second Member Of “Boogaloo Bois” Pleads Guilty to Conspiracy to Provide Material Support to HamasBy Sam NewsMay 4, 2021A Minnesota man pleaded guilty today to conspiracy to provide material support and resources, namely property, services and weapons, to what he believed was Hamas, a designated foreign terrorist organization, for use against Israeli and U.S. military personnel overseas.[Read More…]
- Broiler Chicken Producer Indicted for Price Fixing and Bid RiggingBy Sam NewsMay 20, 2021A federal grand jury in Denver, Colorado, returned an indictment charging Norman W. Fries Inc., dba Claxton Poultry Farms (Claxton), headquartered in Claxton, Georgia, with participating in a nationwide conspiracy to fix prices and rig bids for broiler chicken products.[Read More…]
- Science & Tech Spotlight: Vaccine SafetyBy Sam NewsFebruary 24, 2021Why this Matters Safe vaccines are critical to fighting diseases, from polio to COVID-19. Research shows that the protection provided by U.S. licensed vaccines outweighs their potential risks. However, misinformation and unjustified safety concerns can cause people to delay or refuse vaccination, which may increase preventable deaths and prolong negative social and economic impacts. The Science What is it? A vaccine is generally considered safe when the benefits of protecting an individual from disease outweigh the risks from potential side effects (fig. 1). The most common side effects stem from the body's immune reaction and include swelling at the injection site, fever, and aches. Figure 1. Symptoms of polio and side effects of the polio vaccine. A vaccine is generally considered safe if its benefits (preventing disease) outweigh its risks (side effects). In rare cases, some vaccines may cause more severe side effects. For example, the vaccine for rotavirus—a childhood illness that can cause severe diarrhea, dehydration, and even death—can cause intestinal blockage in one in 100,000 recipients. However, the vaccine is still administered because this very rare side effect is outweighed by the vaccine's benefits: it saves lives and prevents an estimated 40,000 to 50,000 childhood hospitalizations in the U.S. each year. The two messenger RNA (mRNA) vaccines authorized for COVID-19—a disease that contributed to more than 415,000 American deaths between January 2020 and January 2021—can cause severe allergic reactions. However, early safety reporting found that these reactions have been extremely rare, with only about five cases per 1 million recipients, according to data from January 2021 reports by the Centers for Disease Control and Prevention. In general, side effects from vaccines are less acceptable to the public than side effects from treatments given to people who already have a disease. What is known? Vaccine developers assess safety from early research, through laboratory and animal testing, and even after the vaccine is in use (fig. 2). Researchers may rely on previous studies to inform future vaccine trials. For example, safety information from preclinical trials of mRNA flu vaccine candidates in 2017 allowed for the acceleration of mRNA COVID-19 vaccine development. Vaccine candidates shown to be safe in these preclinical trials can proceed to clinical trials in humans. In the U.S., clinical trials generally proceed through three phases of testing involving increasing numbers of volunteers: dozens in phase 1 to thousands in phase 3. Although data may be collected over years, most common side effects are identified in the first 2 months after vaccination in clinical trials. After reviewing safety and other data from vaccine studies, the Food and Drug Administration (FDA) may license a vaccine to be marketed in the U.S. There are also programs to expedite—but not bypass—development and review processes, such as a priority review designation, which shortens FDA’s goal review time from 10 to 6 months. Safety monitoring continues after licensing. For example, health officials are required to report certain adverse events—such as heart problems—following vaccination, in order to help identify potential long-term or rare side effects that were not seen in clinical trials and may or may not be associated with the vaccine. Figure 2. Vaccine safety is assessed at every stage: development through post-licensure. Following a declared emergency, FDA can also issue emergency use authorizations (EUA) to allow temporary use of unlicensed vaccines if there is evidence that known and potential benefits of the vaccine outweigh known and potential risks, among other criteria. As of January 2021, two COVID-19 vaccines had received EUAs, after their efficacy and short-term safety were assessed through large clinical trials. However, developers must continue safety monitoring and meet other requirements if they intend to apply for FDA licensure to continue distribution of these vaccines after the emergency period has ended. What are the knowledge gaps? One knowledge gap that can remain after clinical trials is whether side effects or other adverse events may occur in certain groups. For example, because clinical trials usually exclude certain populations, such as people who are pregnant or have existing medical conditions, data on potential adverse events related to specific populations may not be understood until vaccines are widely administered. In addition, it can be difficult to determine the safety of new vaccines if outbreaks end suddenly. For example, vaccine safety studies were hindered during the 2014-2015 Ebola epidemic when a large increase in the number of cases was followed by a sharp decrease. This disrupted the clinical trials of Ebola vaccine candidates, because the trials require many infected and non-infected people. Furthermore, a lack of understanding and/or misinformation about the steps taken to ensure the safety of vaccines hinders accurate public knowledge about safety concerns, which may cause people to delay or refuse vaccination. This resulting hesitancy may, in turn, increase deaths, social harm, and economic damage. Opportunities Continuing and, where necessary, improving existing vaccine safety practices offers the following opportunities to society: Herd immunity. Widespread immunity in a population, acquired in large part through safe and effective vaccines, can slow the spread of infection and protect those most vulnerable. Health care improvements. Vaccinations can reduce the burden on the health care system by reducing severe symptoms that require individuals to seek treatment. Eradication. Safe vaccination programs, such as those combatting smallpox, may eliminate diseases to the point where transmission no longer occurs. Challenges There are a number of challenges to ensuring safe vaccines: Public confidence. Vaccine hesitancy, in part due to misinformation or historic unethical human experimentation, decreases participation in clinical trials, impeding identification of side effects across individuals with different racial, ethnic, and socioeconomic backgrounds. Mutating viruses. Some viruses, such as those that cause the flu or COVID-19, may mutate rapidly and thus may require new or updated vaccines, for which ongoing safety monitoring is important. Long-term and rare effects. Exceedingly rare or long-term effects may not be identified until after vaccines have been widely administered. Further study is needed to detect any such effects and confirm they are truly associated with the vaccine. Policy Context & Questions What steps can policymakers take to improve public trust and understanding of the process of assessing vaccine safety? How can policymakers convey the social importance of vaccines to protect the general public and those who are most vulnerable? How can policymakers leverage available resources to support ongoing vaccine development and post-licensure safety monitoring? For more information, contact Karen Howard at (202) 512-6888 or HowardK@gao.gov.[Read More…]
- Secretary Blinken’s Call with Saudi Foreign Minister Faisal bin Farhan Al SaudBy Sam NewsMay 27, 2021
- Fake Title – Maintenance (4/18)By Sam NewsApril 14, 2021GAO Email Notification Test We are testing our notification distribution process for GAO reports. If you are able to read this information the link contained in the email notification link worked. Please confirm that you received the email notification from GAOReports@gao.gov and used the link to access the prepublication site by contacting Andrea Thomas at email@example.com (202) 512-3147 John Miller at firstname.lastname@example.org (202) 512-3672 Thank you[Read More…]
- Public Schedule – July 30, 2021By Sam NewsJuly 31, 2021
- [Protest of BOP Cancellation of Solicitation for Correctional Facility Construction]By Sam NewsAugust 17, 2021A firm protested the Bureau of Prisons' (BOP) cancellation of a solicitation for correctional facility construction, contending that BOP: (1) improperly cancelled the solicitation, since the specifications were not defective; and (2) should have made award to it, since it was the low bidder. GAO held that BOP properly cancelled the solicitation, since the conflicting specifications: (1) misled bidders and precluded them from competing on an equal basis; and (2) prejudiced the other bidders regarding the applicability of certain sales taxes. Accordingly, the protest was denied.[Read More…]
- Army and Marine Corps Training: Metrics Needed to Assess Initiatives on Training Management SkillsBy Sam NewsAugust 23, 2021Over the past decade, Army and Marine Corps forces have deployed repeatedly with limited time between deployments. At their home stations, combat training centers, and other locations, units have focused their limited training time on training for counterinsurgency operations. Prior to deploying, units also conduct a large-scale exercise referred to as a culminating training event. With the drawdown of forces in Iraq, the services have begun to resume training for a fuller range of offensive, defensive, and stability missions. The House report to the National Defense Authorization Act for Fiscal Year 2011 directed GAO to report on the Army's and Marine Corps' abilities to complete training requirements. GAO assessed the extent to which the services' (1) active component forces are completing training prior to the culminating training event and (2) leaders are positioned to plan and manage training as forces resume training for a fuller range of missions. GAO analyzed training requirements and unit training documentation, and interviewed headquarters and unit personnel during site visits between July 2010 and July 2011.Deploying Army and Marine Corps units conduct extensive predeployment training--both individual and collective, to include a large-scale culminating training event--at their home stations, combat training centers, and other locations. However, several factors, such as limited training time between deployments, the large number of training requirements, and the current focus on counterinsurgency operation training have been preventing units from completing all desired training prior to the culminating training event. For example, based on GAO's site visits, 7 of 13 units were not able to complete all of the desired individual and collective training (e.g., company-level live fire training) prior to arriving at the combat training centers. Further, officials from all of the units GAO spoke with stated that they planned to delay certain training until they were at the combat training centers since resources--such as theater-specific equipment like mine resistant ambush protected vehicles--were more readily available there. GAO found that some units had to train to improve proficiency levels at the combat training centers prior to beginning the culminating training events, and therefore were not always able to take full advantage of the training opportunities available to them at the combat training centers to conduct complex, higher-level training. Still, according to trainers at the combat training centers, while units arrive with varying levels of proficiency, all forces leave with at least the platoon level proficiency required to execute the counterinsurgency missions required for ongoing operations in Iraq and Afghanistan. Over the past decade, continuous overseas deployments have reduced training timeframes and resulted in senior leaders assuming training management responsibilities from junior leaders. Specifically, leaders at higher headquarters have taken responsibility for much of the training management function--planning, preparing, and assessing training--while junior leaders have focused primarily on training execution. However, changing conditions, such as increased competition for resources in a constrained fiscal environment, increased time at home station, and a return to training for a fuller range of missions, make it imperative that all leaders possess a strong foundation in training management. The services are developing various initiatives to restore and develop training management skills in their leaders, but neither service has developed results-oriented performance metrics to gauge the effectiveness of their efforts to restore these skills. As GAO has previously reported, establishing metrics can help federal agencies target training investments and assess the contributions that training programs make to improving results. Without a means of measuring the effectiveness of their efforts, the Army and Marine Corps will not have the information they need to assess the extent to which their leaders have the training management skills needed to plan, prepare, and assess required training. GAO recommends that the services develop results-oriented performance metrics that can be used to evaluate the effectiveness of their training management initiatives and support any adjustments that the services may need to make to these initiatives. DOD concurred with this recommendation.[Read More…]
- Release of American Hostages Held in YemenBy Sam NewsOctober 14, 2020Michael R. Pompeo, [Read More…]
- Key Outcomes at the 47th Session of the UN Human Rights CouncilBy Sam NewsJuly 16, 2021